Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
Sintilimab bij niet-resectabel adenocarcinoom van de maag of gastro-oesofageale overgang
mrt 2024 | Immuuntherapie, Maag-darm-leveroncologie